Early Identification of Subclinical Atherosclerosis Using Non-Invasive Imaging Research (EISNER)

Completed · Not applicable

Conditions studied: Atherosclerosis, Coronary Artery Disease

In brief

Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research (EISNER) is a multi-study research program being conducted at Cedars-Sinai Medical Center. The principal objective of this randomized trial (referred to as "Study 1") is to assess whether coronary artery calcium (CAC) scanning provides clinical benefit thus improving patient outcomes in asymptomatic subjects with intermediate coronary artery disease (CAD) risk. Additionally, the study is designed to assess the value of combining the CAC scan with the Framingham risk score (FRS) and measurements of serum or plasma biomarkers to predict outcomes.

Key facts

Study ID
NCT00927693
Run by
Cedars-Sinai Medical Center
People needed
2137
Starts
2001-02-01
Expected to finish
2010-08-01
Last updated by the study team
2011-09-29

Who can join

Age: 45 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.